
Gennova Biopharma Partners with CEPI to Develop mRNA Nipah Vaccine
April 1, 2025
Gennova Biopharmaceuticals, a subsidiary of Emcure Pharmaceuticals, has announced a partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a self-amplifying mRNA (saRNA) vaccine for the Nipah virus. The collaboration has secured up to $13.38 million in funding








